Managed Healthcare Executive July 10, 2024
One theme of the Federal Trade Commission’s interim take on pharmacy benefit managers is vertical integration and how that affects competition in the industry.
The gist and tenor of the interim 73-page report on pharmacy benefit managers (PBMs) released by the Federal Trade Commission (FTC) yesterday is captured in the title: “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies.”
The NationalCommunity Pharmacists Association, the trade association for independent and small chain pharmacies and a longtime critic of the PBM industry, trumpeted the “scathing” findings and urged the FTC to “continue its investigation and pursue the information that the PBMs have so far defiantly withheld.”
Just as predictably, the PBMs’ trade association, Pharmaceutical Care Management...
Today's Sponsors
Today's Sponsor